These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Hampl J, Schierholz J, Jansen B, Aschoff A. Acta Neurochir (Wien); 1995 Sep; 133(3-4):147-52. PubMed ID: 8748757 [Abstract] [Full Text] [Related]
3. Biofilm-related infections of cerebrospinal fluid shunts. Fux CA, Quigley M, Worel AM, Post C, Zimmerli S, Ehrlich G, Veeh RH. Clin Microbiol Infect; 2006 Apr; 12(4):331-7. PubMed ID: 16524409 [Abstract] [Full Text] [Related]
4. Ventricular sepsis and abdominally related complications in children with cerebrospinal fluid shunts. Rush DS, Walsh JW, Belin RP, Pulito AR. Surgery; 1985 Apr; 97(4):420-7. PubMed ID: 3983817 [Abstract] [Full Text] [Related]
5. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, Kunze S, Aschoff A. J Med Microbiol; 2000 May; 49(5):441-450. PubMed ID: 10798557 [Abstract] [Full Text] [Related]
6. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. Bayston R, Lambert E. J Neurosurg; 1997 Aug; 87(2):247-51. PubMed ID: 9254088 [Abstract] [Full Text] [Related]
8. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI. J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278 [Abstract] [Full Text] [Related]
9. Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Schierholz JM, Pulverer G. Zentralbl Bakteriol; 1997 Jun; 286(1):107-23. PubMed ID: 9241806 [Abstract] [Full Text] [Related]